Tequin Breaking News & Warnings

Antibotic Tequin has recently been found to cause the dangerous side effects hypoglycemia and hyperglycemia. Below are news articles that show the currently research on Tequin. If you or a loved one has suffered due to Tequin use, fill out this simple form for a free case review within 24 hours.

Antibiotic Tequin To Disappear Soon

May. 02, 2006 (kentucky.com)

An antibiotic plagued by serious blood-sugar complications is coming off the market. Bristol-Myers Squibb Co. confirmed yesterday that it plans to stop making and selling Tequin. Spokesman Eric Miller said the company acted after a commercial evaluation of the product, as well as transition in the company's focus.

Study reveals risk to Tequin patients

March 2, 2006 (newsday.com)

Scientists at the Sunnybrook and Women's Science Center in Toronto have studied more than 1,260 patients hospitalized for complications from blood glucose who had received an antibiotic in the 30 days preceding their admission. They looked back to see who among them had received Tequin, the antibiotic in question. Tequin (gatifloxacin), developed by Bristol-Myers Squibb, was federally approved in 1999. About 5,000 prescriptions of the antibiotic are written each day for a variety of bacterial infections. Early on, the company reported some risk for blood-sugar problems, but it was always associated with a history of diabetes and it was not known how common the problem is

Tequin Linked to High Risk of Dangerous Glucose Changes

March 2, 2006 (medpagetoday.com)

TORONTO, March 1 - The antibiotic Tequin (gatifloxacin) has been associated with a sharply elevated rate of hypoglycemia and hyperglycemia when older patients were treated with the agent for infections.

Patients in their 70s treated with Tequin were four times more likely to develop hypoglycemia and 17 times more likely to be hospitalized for hyperglycemia than similar patients treated with Biaxin (clarithromycin) or Zithromax (azithromycin), investigators here reported.

Stronger Warning for Antibiotic Tequin

Feb. 24, 2006 (webmd.com)

The FDA has added a warning against the use of the antibiotic Tequin in people with diabetes after reports of problems with high blood sugar and low blood sugar associated with the drug.

Weitz & Luxenberg is no longer accepting Tequin cases.

see also:

Tequin Recall Tequin - Is Tequin being recalled? Are you being hurt by Tequin?
Tequin Recall - Discover the dangers of Tequin - FREE Tequin Advice

FDA Label Changes Tequin Breaking News - FDA Labeling Changes due to Dangerous Side Effects
FDA requiring Tequin to change label for Warnings about Hypoglycemia

News & Warnings Tequin Breaking News & Warnings
Breaking News Stories about the dangerous antibotic drug Tequin